11-535777-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001441284.1(LRRC56):​c.-161-3803G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.14 in 151,944 control chromosomes in the GnomAD database, including 2,087 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.14 ( 2087 hom., cov: 33)

Consequence

LRRC56
NM_001441284.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.238

Publications

3 publications found
Variant links:
Genes affected
LRRC56 (HGNC:25430): (leucine rich repeat containing 56) Predicted to be involved in cell projection organization. Predicted to be located in cilium. Implicated in primary ciliary dyskinesia 39. [provided by Alliance of Genome Resources, Apr 2022]
HRAS (HGNC:5173): (HRas proto-oncogene, GTPase) This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. Mutations in this gene cause Costello syndrome, a disease characterized by increased growth at the prenatal stage, growth deficiency at the postnatal stage, predisposition to tumor formation, cognitive disability, skin and musculoskeletal abnormalities, distinctive facial appearance and cardiovascular abnormalities. Defects in this gene are implicated in a variety of cancers, including bladder cancer, follicular thyroid cancer, and oral squamous cell carcinoma. Multiple transcript variants, which encode different isoforms, have been identified for this gene. [provided by RefSeq, Jul 2008]
HRAS Gene-Disease associations (from GenCC):
  • Costello syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • rhabdomyosarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome-like disorder with loose anagen hair
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.276 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001441284.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRRC56
NM_001441284.1
c.-161-3803G>T
intron
N/ANP_001428213.1
LRRC56
NM_001441286.1
c.-161-3803G>T
intron
N/ANP_001428215.1
HRAS
NM_005343.4
MANE Select
c.-415C>A
upstream_gene
N/ANP_005334.1P01112-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HRAS
ENST00000932528.1
c.-53-1402C>A
intron
N/AENSP00000602587.1
HRAS
ENST00000932529.1
c.-54+1092C>A
intron
N/AENSP00000602588.1
HRAS
ENST00000932530.1
c.-54+363C>A
intron
N/AENSP00000602589.1

Frequencies

GnomAD3 genomes
AF:
0.140
AC:
21307
AN:
151836
Hom.:
2084
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.280
Gnomad AMI
AF:
0.0473
Gnomad AMR
AF:
0.106
Gnomad ASJ
AF:
0.0790
Gnomad EAS
AF:
0.0544
Gnomad SAS
AF:
0.0280
Gnomad FIN
AF:
0.0610
Gnomad MID
AF:
0.140
Gnomad NFE
AF:
0.0942
Gnomad OTH
AF:
0.137
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.140
AC:
21329
AN:
151944
Hom.:
2087
Cov.:
33
AF XY:
0.137
AC XY:
10152
AN XY:
74270
show subpopulations
African (AFR)
AF:
0.280
AC:
11599
AN:
41374
American (AMR)
AF:
0.106
AC:
1625
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0790
AC:
274
AN:
3468
East Asian (EAS)
AF:
0.0545
AC:
281
AN:
5152
South Asian (SAS)
AF:
0.0280
AC:
135
AN:
4826
European-Finnish (FIN)
AF:
0.0610
AC:
646
AN:
10594
Middle Eastern (MID)
AF:
0.147
AC:
43
AN:
292
European-Non Finnish (NFE)
AF:
0.0942
AC:
6396
AN:
67926
Other (OTH)
AF:
0.136
AC:
287
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
832
1664
2496
3328
4160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0377
Hom.:
46
Bravo
AF:
0.150
Asia WGS
AF:
0.0560
AC:
194
AN:
3464

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
4.7
DANN
Benign
0.49
PhyloP100
-0.24
PromoterAI
0.22
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8176332; hg19: chr11-535777; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.